Cite
Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection.
MLA
Wei Gao, et al. “Two Novel Point Mutations in Clinical Staphylococcus Aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection.” PLoS Pathogens, vol. 6, no. 6, June 2010, pp. 1–15. EBSCOhost, https://doi.org/10.1371/journal.ppat.1000944.
APA
Wei Gao, Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes52, N. E., Hyun-Woo Rhee, Jong-In Hong, Hartland, E. L., Stinear, T. P., & Howden, B. P. (2010). Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection. PLoS Pathogens, 6(6), 1–15. https://doi.org/10.1371/journal.ppat.1000944
Chicago
Wei Gao, Kyra Chua, John K. Davies, Hayley J. Newton, Torsten Seemann, Paul F. Harrison, Natasha E. Holmes52, et al. 2010. “Two Novel Point Mutations in Clinical Staphylococcus Aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection.” PLoS Pathogens 6 (6): 1–15. doi:10.1371/journal.ppat.1000944.